Literature DB >> 19006645

Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.

Ikuhiko Nakase1, Byron Gallis, Tomoka Takatani-Nakase, Steve Oh, Eric Lacoste, Narendra P Singh, David R Goodlett, Seigo Tanaka, Shiroh Futaki, Henry Lai, Tomikazu Sasaki.   

Abstract

Artemisinin, a natural product isolated from Artemisia annua, contains an endoperoxide group that can be activated by intracellular iron to generate toxic radical species. Cancer cells over-express transferrin receptors (TfR) for iron uptake while most normal cells express nearly undetectable levels of TfR. We prepared a series of artemisinin-tagged transferrins (ART-Tf) where different numbers of artemisinin units are attached to the N-glycoside chains of transferrin (Tf). The Tf bearing approximately 16 artemisinins retains the functionality of both Tf and artemisinin. Reduction of TfRs by TfR siRNA transfection significantly impaired the ability of ART-Tf, but not dihydroartemisinin, to kill cells. We also demonstrate that the ART-Tf conjugate kills the prostate carcinoma cell line DU 145 by the mitochondrial pathway of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006645     DOI: 10.1016/j.canlet.2008.09.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

Review 1.  Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.

Authors:  Yulin Ren; Jianhua Yu; A Douglas Kinghorn
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Preparation and investigation of bioactive transferrin-iron complexes formed with different synergistic anions.

Authors:  Judit Gálicza; Andrea Vargová; Viktor Sándor; Csongor Kálmán Orbán; Csaba Dezso András; Beáta Abrahám; Szabolcs Lányi; Ferenc Kilár
Journal:  Protein J       Date:  2012-01       Impact factor: 2.371

4.  Synergic effects of artemisinin and resveratrol in cancer cells.

Authors:  Peichun Li; Sen Yang; Mengmeng Dou; Youran Chen; Jie Zhang; Xiaoyan Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-22       Impact factor: 4.553

Review 5.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

Review 6.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

7.  MR reporter gene imaging of endostatin expression and therapy.

Authors:  Kai Wang; Kezheng Wang; Baozhong Shen; Tao Huang; Xilin Sun; Weihua Li; Gang Jin; Lin Li; Lihong Bu; Renfei Li; Dan Wang; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2009-12-03       Impact factor: 3.488

Review 8.  Potential applications of artemisinins in ocular diseases.

Authors:  Bing-Wen Lu; Li-Ke Xie
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

9.  Evaluation of artemisinins for the treatment of acute myeloid leukemia.

Authors:  Christina D Drenberg; Jassada Buaboonnam; Shelley J Orwick; Shuiying Hu; Lie Li; Yiping Fan; Anang A Shelat; R Kiplin Guy; Jeffrey Rubnitz; Sharyn D Baker
Journal:  Cancer Chemother Pharmacol       Date:  2016-04-28       Impact factor: 3.333

10.  The Circular RNA circSKA3 Binds Integrin β1 to Induce Invadopodium Formation Enhancing Breast Cancer Invasion.

Authors:  William W Du; Weining Yang; Xiangmin Li; Ling Fang; Nan Wu; Feiya Li; Yu Chen; Qihan He; Elizabeth Liu; Zhenguo Yang; Faryal Mehwish Awan; Mingyao Liu; Burton B Yang
Journal:  Mol Ther       Date:  2020-03-10       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.